Medication exclusions are becoming more common The number of formulary exclusions has risen steadily over the last decade
BPC Wolverine is an injectable peptide therapy that combines two well-known recovery peptides BPC-157 and TB-500 that together support healing, tissue repair, and inflammation control
Difficulty breathing has been reported in certain cases involving compounded injectable formulations
BMC Complement Altern Med 19:18 Qiu H, Fu P, Fan W, Zuo C, Feng P, Shi P, Cao L, Liu F, Zhou L, Chen F (2014) Treatment of primary chronic glomerulonephritis with Rehmannia glutinosa acteosides in combination with the angiotensin receptor blocker irbesartan: a randomized controlled trial
Novo Nordisk's Kamogelo Mmako told Spotlight: "We have not publicly announced launch timing for Rybelsus or Wegovy in South Africa." Tirzepatide After semaglutide, tirzepatide is probably the next best known GLP-1 agonist